These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33978986)

  • 21. Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010.
    McCoy RG; Zhang Y; Herrin J; Denton BT; Mason JE; Montori VM; Smith SA; Shah ND
    Am J Manag Care; 2015 May; 21(5):e288-96. PubMed ID: 26167776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
    Xu Y; Pilla SJ; Alexander GC; Murimi IB
    PLoS One; 2019; 14(2):e0211820. PubMed ID: 30759121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.
    Currie CJ; Poole CD; Gale EA
    Diabetologia; 2009 Sep; 52(9):1766-77. PubMed ID: 19572116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
    Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
    Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to metformin monotherapy in people with type 2 diabetes mellitus in New Zealand.
    Horsburgh S; Barson D; Zeng J; Sharples K; Parkin L
    Diabetes Res Clin Pract; 2019 Dec; 158():107902. PubMed ID: 31672501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
    Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
    Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus.
    Oktora MP; de Vos S; de Vries ST; Hak E; Denig P
    Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1395-1405. PubMed ID: 37524658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liraglutide in Children and Adolescents with Type 2 Diabetes.
    Tamborlane WV; Barrientos-Pérez M; Fainberg U; Frimer-Larsen H; Hafez M; Hale PM; Jalaludin MY; Kovarenko M; Libman I; Lynch JL; Rao P; Shehadeh N; Turan S; Weghuber D; Barrett T;
    N Engl J Med; 2019 Aug; 381(7):637-646. PubMed ID: 31034184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective cohort analysis of hypoglycaemic and cardiovascular agent use in young adults in the Irish primary care setting.
    Grimes RT; Bennett K; Hoey H; Tilson L; Henman MC
    Ir J Med Sci; 2017 May; 186(2):461-470. PubMed ID: 27534545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.
    Lewin A; Lipetz R; Wu J; Schwartz S
    Clin Ther; 2007 May; 29(5):844-855. PubMed ID: 17697903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study.
    Kelsey MM; Geffner ME; Guandalini C; Pyle L; Tamborlane WV; Zeitler PS; White NH;
    Pediatr Diabetes; 2016 May; 17(3):212-21. PubMed ID: 25690268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin.
    Jalaludin MY; Deeb A; Zeitler P; Garcia R; Newfield RS; Samoilova Y; Rosario CA; Shehadeh N; Saha CK; Zhang Y; Zilli M; Scherer LW; Lam RLH; Golm GT; Engel SS; Kaufman KD; Shankar RR
    Pediatr Diabetes; 2022 Mar; 23(2):183-193. PubMed ID: 34779103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [De-escalation of antihyperglycemic treatment in patients with type 2 diabetes - when less is more].
    Jermendy G
    Orv Hetil; 2019 Aug; 160(31):1207-1215. PubMed ID: 31352807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study.
    Wolf RM; Cheng P; Gal RL; Beaulieu LC; Kollman C; Isganaitis E; Magge S; Mastrandrea LD; Klingensmith GJ; Tamborlane W; Van Name M;
    Pediatr Diabetes; 2022 Jun; 23(4):439-446. PubMed ID: 35138021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications.
    Tseng YJ; Steinberg G; Fox KP; Armstrong J; Mandl KD
    Diabetes Care; 2017 Nov; 40(11):1500-1505. PubMed ID: 28903978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Determinants of Diabetes Progression in Multiethnic Asians with Type 2 Diabetes - A 3-Year Prospective Cohort Study.
    Liu S; Liu JJ; Gurung RL; Chan C; Yeo D; Ang K; Tang WE; Tavintharan S; Sum CF; Lim SC
    Ann Acad Med Singap; 2019 Jul; 48(7):217-223. PubMed ID: 31495867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.